Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 41.505 USD -1.51% Market Closed
Market Cap: 16B USD
Have any thoughts about
Moderna Inc?
Write Note

Moderna Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Moderna Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Moderna Inc
NASDAQ:MRNA
Revenue
$5.1B
CAGR 3-Years
-25%
CAGR 5-Years
129%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%

Moderna Inc
Revenue Breakdown

Breakdown by Geography
Moderna Inc

Total Revenue: 6.8B USD
100%
Rest Of World: 3.6B USD
52.5%
United States: 1.9B USD
27.7%
Europe: 1.4B USD
19.8%

Breakdown by Segments
Moderna Inc

Total Revenue: 6.8B USD
100%
Net Product Sales: 6.7B USD
97.4%
Other Revenue: 177m USD
2.6%
Grant Revenue: 94m USD
1.4%
Collaboration Revenue: 83m USD
1.2%
Show More
Show Less

See Also

What is Moderna Inc's Revenue?
Revenue
5.1B USD

Based on the financial report for Sep 30, 2024, Moderna Inc's Revenue amounts to 5.1B USD.

What is Moderna Inc's Revenue growth rate?
Revenue CAGR 5Y
129%

Over the last year, the Revenue growth was -44%. The average annual Revenue growth rates for Moderna Inc have been -25% over the past three years , 129% over the past five years .

Back to Top